GLP-1RAs: what does the future hold?

27 August 2023 (13:15 - 13:25)

Organised by:

About the speaker

Doctor Tina Vilsboll

Copenhagen University Hospital, Copenhagen (Denmark)

5 More presentations in this session

Presentation thumbnail

Welcome and introductions: cardiovascular risk in people with type 2 diabetes and/or obesity

Professor N. Marx (Aachen, DE)

Presentation thumbnail

The effect of GLP-1RAs on cardiovascular disease and cardio-metabolic risk factors in patients with obesity and/or type 2 diabetes

Professor S. Verma (Toronto, CA)

Presentation thumbnail

A focus on the practical: how can cardiologists best utilise GLP-1RAs in the clinic?

Professor N. Marx (Aachen, DE)

Presentation thumbnail

Panel discussion and Q&A

Presentation thumbnail

Closing

Professor N. Marx (Aachen, DE)

Access the full session

Session thumbnail

A multidisciplinary approach to type 2 diabetes, obesity, and cardiovascular diseases: current evidence and a glimpse into the future

The Event

Event poster

ESC Congress 2023

27 August 2023 13:15 CET

You may be interested in

Congress Presentation

Practical considerations for the use of GLP-1 RAs in the clinic.

28 August 2022

Webinar

GLP-1 RAs and HFpEF : what do we know from large RCTs about GLP-1 RAs and their effects on HFpEF?

24 November 2025

Congress Presentation

GLP1-RA versus metformin as first-line therapy for achieving glycemic control and risk-factor management - a one-year nationwide cohort study

28 August 2023

Congress Presentation

Persistence and Adherence to GLP-1 RA treatment in Type 2 Diabetes Mellitus: a Nationwide registry study

31 August 2024

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources